Comparing treatment effects of a convenient vibratory positional device to CPAP in positional OSA: a crossover randomised controlled trial
- PMID: 31896735
- PMCID: PMC7231442
- DOI: 10.1136/thoraxjnl-2019-213547
Comparing treatment effects of a convenient vibratory positional device to CPAP in positional OSA: a crossover randomised controlled trial
Abstract
Objectives: Up to 77% of patients with obstructive sleep apnoea (OSA) have positional OSA (POSA) but traditional positional therapy (PT) methods have failed as they were poorly tolerated. New convenient vibratory PT devices have been invented but while recent studies suggest high treatment efficacy and adherence, there are no published data comparing these devices directly with continuous positive airway pressure (CPAP). Our objective is to evaluate if a convenient vibratory PT device is non-inferior to CPAP in POSA treatment.
Methods: In this crossover randomised controlled trial, we enrolled patients with POSA with significant daytime sleepiness (Epworth Sleepiness Scale (ESS)≥10). POSA diagnosis was based on: (1) total Apnoea/Hypopnoea Index (AHI)>10/hour and non-supine AHI<10/hour (2) supine AHI≥2 × non-supine AHI. Patients used their initial allocated devices (PT or CPAP) for 8 weeks before crossing to the alternative intervention after a 1 week washout. The primary aim is to measure changes in ESS between the two treatments. Secondary outcomes include sleep study parameters and patient treatment preference (ClinicalTrials.gov: NCT03125512).
Results: 40 patients completed the trial between April 2017 and December 2018. Difference in ESS after 8 weeks of device use (PT minus CPAP) was 2.0 (95% CI 0.68 to 3.32), exceeding our predetermined non-inferiority margin of 1.5. AHI on CPAP was lower than with PT (4.0±3.2 vs 13.0±13.8 events/hour, respectively, p=0.001), although both were lower than at baseline. Time spent supine was significantly lower with PT than CPAP (p<0.001). 60% of patients preferred CPAP, 20% preferred PT, while 20% preferred neither device.
Conclusions: The non-inferiority ESS endpoint for PT compared with CPAP was not met and the results were inconclusive. Future trials with larger sample sizes or in less symptomatic patients are warranted to provide further insight into the role of these new vibratory PT devices.
Keywords: sleep apnoea.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures




Comment in
-
'Good vibrations': positional treatments for obstructive sleep apnoea.Thorax. 2020 Apr;75(4):296. doi: 10.1136/thoraxjnl-2019-214404. Epub 2020 Mar 8. Thorax. 2020. PMID: 32152178 No abstract available.
-
Alternative and Complementary Treatments for Obstructive Sleep Apnea.Am J Respir Crit Care Med. 2021 Nov 1;204(9):1097. doi: 10.1164/rccm.202102-0452RR. Am J Respir Crit Care Med. 2021. PMID: 34406912 No abstract available.
Similar articles
-
Efficacy of vibrotactile positional therapy devices on patients with positional obstructive sleep apnoea: a systematic review and meta-analysis.Thorax. 2023 Nov;78(11):1126-1134. doi: 10.1136/thorax-2021-218402. Epub 2023 Jun 21. Thorax. 2023. PMID: 37344178 Free PMC article.
-
Positional therapy for obstructive sleep apnoea.Cochrane Database Syst Rev. 2019 May 1;5(5):CD010990. doi: 10.1002/14651858.CD010990.pub2. Cochrane Database Syst Rev. 2019. PMID: 31041813 Free PMC article.
-
Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.Health Technol Assess. 2014 Oct;18(67):1-296. doi: 10.3310/hta18670. Health Technol Assess. 2014. PMID: 25359435 Free PMC article. Clinical Trial.
-
Mandibular advancement device vs. CPAP in the treatment of obstructive sleep apnea: are they equally effective in Short term health outcomes?J Clin Sleep Med. 2013 Sep 15;9(9):971-2. doi: 10.5664/jcsm.3008. J Clin Sleep Med. 2013. PMID: 23997711 Free PMC article.
-
Positional OSA part 1: Towards a clinical classification system for position-dependent obstructive sleep apnoea.Sleep Breath. 2015 May;19(2):473-80. doi: 10.1007/s11325-014-1022-9. Epub 2014 Jun 19. Sleep Breath. 2015. PMID: 24943728
Cited by
-
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea.Eur Respir Rev. 2021 Nov 30;30(162):210200. doi: 10.1183/16000617.0200-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34853097 Free PMC article.
-
Positional therapy: is it ready for prime time?J Clin Sleep Med. 2025 Feb 1;21(2):221-222. doi: 10.5664/jcsm.11510. J Clin Sleep Med. 2025. PMID: 39625191 No abstract available.
-
The role of positional changes in optimizing OSA treatment: evidence from DISE.Eur Arch Otorhinolaryngol. 2025 May;282(5):2709-2717. doi: 10.1007/s00405-025-09314-y. Epub 2025 Mar 10. Eur Arch Otorhinolaryngol. 2025. PMID: 40064683 Free PMC article.
-
Patient compliance and satisfaction with a new forehead device for positional obstructive sleep apnoea treatment: a post hoc analysis of a randomised controlled trial.BMJ Open Respir Res. 2023 Jun;10(1):e001503. doi: 10.1136/bmjresp-2022-001503. BMJ Open Respir Res. 2023. PMID: 37349132 Free PMC article. Clinical Trial.
-
Efficacy of vibrotactile positional therapy devices on patients with positional obstructive sleep apnoea: a systematic review and meta-analysis.Thorax. 2023 Nov;78(11):1126-1134. doi: 10.1136/thorax-2021-218402. Epub 2023 Jun 21. Thorax. 2023. PMID: 37344178 Free PMC article.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous